U002 - Don't Brush it Off: Diagnosis and Management of Hair Loss in Children
Thursday, July 25; 7:30 AM - 8:30 AM
Following this course, the attendee should be able to:
- Develop a differential diagnosis for children presenting with hair disorders.
- Identify patients for whom additional diagnostic workup is warranted.
- Formulate treatment plans for a variety of diagnoses, from basic to complex.
Hair loss in children is often straightforward, caused by conditions such as tinea capitis or alopecia areata that typically present with fairly classic clinical features. In some cases, however, hair loss results from a variety of less common conditions and diagnosis and management can be more challenging. This session will use a case-based approach to review both common and rare causes of alopecia in children, with special focus paid to clinical findings and diagnostic workup. Treatment options for a variety of diagnoses will be presented, including the use of Janus kinase inhibitors for alopecia areata.
- Craiglow, Brittany Gareth, MD: Aclaris Therapeutics Inc. – A(H), C(Fees); Celgene – A(Fees); Concert Pharmaceuticals – C(Grants/Research Funding); Eli Lilly and Company – C(Fees); Pfizer Inc. – A(H), C(Fees), I(NC), SP(H); Regeneron Pharmaceuticals, Inc. – A(H), SP(H); Roivant Sciences – C(Fees); Summers Laboratories – O(H);